Summary
A mammary derived growth inhibitor related gene (MRG) was previously identified and characterized. MRG induces differentiation of mammary epithelial cells in vitro and its expression is associated with mammary differentiation. To further define the role of MRG on mammary gland differentiation, a MRG transgenic mice model under the control of MMTV promoter was established and the effect of MRG on mammary gland differentiation was investigated at histological and molecular levels. Expression of endogenous mouse MRG gene was significantly increased from the non-differentiated gland of control virgin mice to the functionally differentiated gland of pregnant control mice. Whole mount analyses demonstrated that ductal development was not affected by MRG transgene expression. While there was no lobulo-alveolar structure in control virgin mice, expression of MRG transgene in the mammary gland resulted in the development of lobuloalveolar-like structure, which mimics the gland from early pregnancy. Consistent with the morphological change, expression of MRG also increased milk protein β-casein expression in the gland. To study the mechanism of MRG-induced mammary differentiation, we investigated the Stat5 activation in the glands from the transgenic mouse vs. virgin control mouse. While activated Stat5 was expressed at the minimal level in the non-differentiated control virgin gland, a significant Stat5 phosphorylation was observed in the virgin transgenic gland. Our data indicate that MRG is mediator of the differentiating effects of pregnancy on breast epithelium and overexpression of MRG in young nulliparous mice can induce differentiation.
Introduction.
In an effort to search for growth regulators in the human mammary gland development, we generated cDNA libraries from a breast cancer biopsy specimen and a normal breast and analyzed these libraries by differential cDNA sequencing (1) (2) . We identified, cloned, and characterized a novel tumor growth inhibitor and named it as a Mammary derived growth inhibitor-Related Gene MRG (3).
The predicted amino acid sequence of MRG has a significant sequence homology to previously identified mammary derived growth inhibitor MDGI (4) . Interestingly, MRG and MDGI revealed no homology to any other known growth inhibitors; rather, they revealed extensive sequence homology to fatty acid binding protein (FABP) (5) (6) . A striking homology was evident between MDGI and Heart type (H-) FABP, which differ only in seven positions of the amino acid sequence (5) . In fact, it turned out that the originally described MDGI is the same protein of H-FABP, which is also expressed in mammary gland (7) (8) . H-FABP fully replaced the MDGI effect and inhibited the growth of mammary epithelial cells (7) . Thus, MDGI was also named as H-FABP. Interestingly, similar to the story of MDGI and H-FABP, subsequent to our isolation of MRG, human brain type (B-) FABP was independently cloned from human fetal whole-brain cDNA library (9) . In fact, the sequence of MRG was found to be exactly identical to the recently deposited sequences of human B-FABP in GenBank (accession #AJ002962). Thus, while the names MRG and MDGI are used when referring their functions on mammary gland, the names of B-FABP and H-FABP are also used when referring their well-accepted FABP family phylogenetic tree (10) .
Cellular FABPs comprise a well-established family of cytoplasmic hydrophobic ligand binding proteins and are thought to be involved in lipid metabolism by binding and intracellular transport of long-chain fatty acids. It has been suggested that in heart and brain, FABPs regulate the supply of fatty acids to the mitochondria for beta-oxidation (11) (12) . The mammary gland, however, is a highly lipogenic tissue and fatty acids are not likely to be a major fuel for its metabolism. However, from other studies on role for FABPs in cell signaling, growth inhibition and differentiation has also been implied (3, (13) (14) . MDGI was mainly detected in myocardium, skeletal and smooth muscle fibres, lipid, and steroid synthesizing cells adrenals, and terminally differentiated epithelia of the respiratory, intestinal and urogenital tracts (15) . Within the similar content, the expression of MRG was mainly detected in brain, heart, and skeletal muscle, which are in the postmitotic status (3). In particular, MDGI (14, 16) and MRG (17) are abundantly expressed in the mammary gland during functional differentiation. These results provide evidence that expression of MRG is associated with an irreversibly postmitotic and terminally differentiated status of cells. Within the phylogenetic tree of FABPs, MRG and MDGI belong to a closely related subfamily of proteins that act as growth inhibitor for breast cancer (18) . Therefore, MRG and MDGI could fulfill different functions in brain and heart compared with mammary gland. Being the members of FABP family, the most characterized biological functions for MRG and MDGI are differentiating effect on mammary cells and tumorsuppressing activities against breast cancer. These include (a) the loss expression of MRG (3) and MDGI (19) is associated with breast cancer progression; (b) Both MRG (17) and MDGI (14, 16) are highly expressed in the fully differentiated lactating mammary gland and induce mammary differentiation; (c) MRG and MDGI have been mapped at the chromosome 6q22-23 (18) and 1p35 (20) that harbor the putative tumor suppressor genes for breast cancer (21) (22) ; and (d) both MRG and MDGI strongly suppress the growth of breast tumors (3, 20) .
It has been previously demonstrated that the expression of mouse MRG is correlated with neuronal differentiation in many parts of the mouse central nervous system (23) (24) and blocking antibody to mouse MRG can block glial cell differentiation in mixed primary cell cultures prepared during the first postnatal week (24) . In mammary epithelium, MRG also induces mammary differentiation (17) . These include that (a) overexpression of MRG in human breast cancer cells induced differentiated cellular morphology and a significant increase in the production of lipid droplets and (b) treatment of mouse mammary gland in organ culture with MRG recombinant protein resulted in a differentiated morphology and production of β-casein (17) . Therefore, it seems clear that a differentiation-associated function is a common property of this structurally related subfamily of FABPs. In the current study, we established MRG transgenic mouse under the promoter of mouse mammary tumor virus (MMTV) and investigated the role of MRG on mammary gland differentiation.
Our data indicate that MRG is a mediator in the differentiation effect of pregnancy on breast epithelial cells and the MRG-induced differentiation is mediated by JAK-Stat5 signaling pathway. Western analysis of MRG protein in mammary gland. Western blot was conducted as we previously described (17) . Briefly, the blot was incubated with anti-MRG primary antibody (1:200 dilution) overnight at 4 0 C, and then incubated with goat anti-rabbit IgG-horseradish peroxidase
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(1:1200 dilution) for 1 h, washed, and visualized by chemiluminescence.
RT-PCR analyses.
RT-PCR analysis was performed by using a standard reversed transcription -PCR with the primers specific for mouse actin, β-casein, and human MRG. Total RNAs were isolated from tissue using the Rnasy MINI Kit (Qiagen). One µg total RNAs were used for RT reaction using Whole mount histological analysis of mammary gland. Whole inguinal mammary glands were removed from virgin control as well as virgin transgenic mice as we previously described (17) .
The removed gland was subjected to whole mount fix, defat, and staining as previously described (26).
Briefly, the inguinal mammary glands were fixed in 75% EtOH, 25% HoAC, and stained with alum carmine (0.1% w/v). Whole mount glands were destained in 70%, 90%, and 100% EtOH, respectively, defatted in xylenes, and stored in methyl salicylate.
Morphological assessment of mammary gland. Whole inguinal mammary glands were
removed from virgin control as well as transgenic mice, fixed in 4% paraformaldehyde, and routine 5-µm sections were stained with hematoxylin and eosin. The characteristic lymph node in each gland was observed.
Treatment of mouse with hCG. Treatment of virgin mouse with hCG was performed as previously described by Russo (27) (28) (29) with some modifications. Briefly, virgin mice were injected i.p.
with hCG 20 U/day for 8 days. The animals were sacrificed; the inguinal mammary glands were removed and subjected to histological analysis. hybridizing RNA samples extracted from various tissues from female mice with MRG full-length cDNA probe. Transgene mRNA was clearly detectable in the mammary gland, no MRG transgene mRNA was detectable in the RNA samples isolated from heart, liver, kidney, lung, and brain (Fig. 3 ).
RESULTS
Screening
As expected, the endogenous mouse MRG gene was present in the heart and brain as the lower band, which is consistent with the MRG expression in the human tissue (3).
Expression of endogenous mouse MRG in mammary gland of control mice. To address the role of endogenous versus the transgenic MRG in breast epithelial differentiation, we analyzed the endogenous MRG protein expression in control virgin mouse vs. control pregnant mouse by Western blot (Fig. 4A ). As expected, while there were limited amounts of endogenous mouse MRG in the gland from virgin mouse, expression of endogenous mouse MRG was significantly increased in the mammary gland during pregnancy. The amount of mouse MRG in the functionally differentiated gland from the pregnant mouse was 5-fold of that in the non-differentiated gland from virgin mice. In a similar pattern, while expression of β-casein was abundant in the gland from pregnant mouse, it was barely detectable in the gland from control virgin mouse (Fig. 4C) .
Effects of expression of MRG transgene on ductal development. Because MRG protein expression was associated with human mammary gland functional differentiation with the highest expression observed in the differentiated alveolar mammary epithelial cells from the lactating gland (17), we were interested in studying whether MRG is an instigator of mammary gland differentiation or merely a correlative product during mammary gland development. The effect of transgene expression on mammary gland development and differentiation was assayed by morphological analyses of ductal elongation and appearance of a differentiated alveolar branching morphogenesis. While the mammary gland development starts at about 3-week old in wild-type mice with ductal elongation and development of the initial branching structure, the functional differentiation starts at the onset of pregnancy with the expansion of secretory lobulo-alveolar architecture (30) . Whole mount preparations of the mammary glands starting at 4-week to 12-week from virgin wild-type and virgin transgenic mice were examined to determine the effect of MRG on mammary gland development. (Fig. 5D ). Similar ductal developments were also observed at different time points, indicating that expression of the transgene did not alter the ductal outgrowth during the early mammary gland development. However, an alternation in the developmental pattern of the branching points of ducts in transgenic virgin mice was observed compared with the control littermate. While the limited budding was developed in the wild-type gland (Fig. 5E ), transgenic gland exhibited multiplicity of budding (Fig. 5F ).
Effects of expression of MRG transgene on gland differentiation and lobuloalveolar development.
The increased budding in the transgenic mice suggests a potential effect of MRG on mammary gland differentiation leading to lobuloalveolar development. Two sets of experiments were done to exam the presence of differentiation of mammary alveolar epithelium in the transgenic mice. First, histological evaluation of H & E stained mammary sections revealed the presence of multiple budding structures in the transgenic mice. There were no morphological differences observed in the younger (4-6-week old) transgenic mice compared to the age-matched control mice. However, starting at 8-week old, a significantly different morphology was observed in the transgenic mice vs. the control mice. As shown in Fig. 6 , whereas no lobuloalveolar structures in the branching points of ducts were present in the 10-week old control virgin mouse (A&B), formation of the alveolar-like structure were observed in the gland from a transgenic mouse (C&D). Since the observed morphology did not look like the fully differentiated phenotype with expanded alveolar lumina containing lipid droplets, we further investigated if the observed phenotype resembles the characteristic alveolar-like structure in the gland during early pregnancy. We compared the morphology of the glands from virgin transgenic mice to the glands from early pregnant (6 days) and the late pregnant (15 days) control mice. The gland from a transgenic mouse exhibited an alveolar-like structure similar to the gland from the 6-day pregnant mouse (Fig. 6F) . In contrast to the glands with alveolar-like structure in the transgenic mouse and the early pregnant mouse, a fully functionally differentiated gland with typical alveolar lumina contained milk was observed in the late pregnant mouse (Fig. 6H ).
Given the fact that mammary gland development and differentiation is controlled by systematic hormones and by a variety of different local growth factors that might complement or mediate hormonal actions, hormone treatment of virgin mice has been used to mimic the effect of early pregnancy on alveolar development. It was previously well established by Russo that treatment of rat with human placental hormone chorionic gonadotropin (hCG) resulted in a similar effect on mammary differentiation as pregnancy (27) (28) (29) . Since MRG-induced alveolar-like structure resembles the phenotype from early pregnant mice, we further compared the histology of MRG-induced alveoli-like structure to that of hormone stimulated alveoli formation. We treated control virgin mice with hCG 20 U/day for 8 days and then the glands were histologically analyzed. As expected, hCG treatment resulted in a tremendous increase in the formation of alveoli-like structure (Fig. 7 E & F) . Although, the magnitude of MRG effect is less than that of hCG on the formation of alveoli-like structure, the MRG-induced formation of alveoli-like structure (Fig. 7C & D) is compatible to that of hCG and is significantly different from the control virgin mice.
Effects of expression of MRG transgene on the gland morphology during pregnancy, lactation, and involution. Female mice that expressed MRG exhibited normal mammary glands function during pregnancy and lactation. Histological analyses of the mammary glands at early pregnancy (6-day), later pregnancy (15-day), and lactation indicated no phenotype difference among control and the transgenic mice (data not shown). The glands from late pregnant and lactating transgenic mice exhibited a normal fully functionally differentiated phenotype with a marked increase in glandular lumen with significant accumulation of milk and secretory material. Transgenic female mice nursed their pups normally and the transgenic pups developed as normal as their nontransgenic littermates.
We also examined the gland morphology at day 2 and day 6 of involution and no distinct morphological differences were apparent between the glands from control and the transgenic mice (data not shown). At day 2 of involution, typical alveolar structures with a single layer of epithelial cells surrounding a lumen are observed in mammary glands from both normal and transgenic mice. At day 6 of involution, the alveoli in mammary glands from both normal mice and transgenic mice have collapsed, and numerous apoptotic bodies were apparent in the ductal lumens.
Stimulation of β-casein expression.
To determine if the mammary epithelial cells were functionally as well as morphologically differentiated, the expression of the early differentiation marker milk protein gene β-casein was analyzed by RT-PCR. Fig. 8 shows a representative MRG transgene and β-casein expression in four virgin control mice and four randomly picked virgin transgenic mice from
MM-H1 and MM-H2 lines. RT-PCR analysis revealed the expression of the transgene MRG and β-
casein in all four transgenic mice (Fig. 8, lines 6-9 ). However, no detectable β-casein transit was observed in age-matched control virgin mice (Fig. 8, lines 1-3 ). As expected, expression of β-casein was detected in an 8-day pregnant of normal mouse (Fig. 8, line 4) . We also investigated the late Epidemiological data and animal studies imply that an early first full-term pregnancy induces the functional differentiation of the gland, which results in a decreased risk for the subsequent development of breast cancer (44) (45) . The protective effect of pregnancy against breast cancer can be attributed to the transition from undifferentiated mammary epithelial cells in the nulliparous to differentiated mature cells during the pregnancy and lactation (28) (29) . A stumbling block in chemoprevention has been the prolonged and costly clinical trials required to determine the efficacy of chemoprevention regimens due to reliance on the development of breast cancer as a clinical end point. 
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